Falcon Edge Capital, managed by Richard Gerson and Navroz D. Udwadia, is a global long/short equity hedge fund. Falcon Edge Capital was founded in 2012...
Keep Reading →
April 2 - Hedge Funds, News - Comments
John Griffin‘s Blue Ridge Capital has managed to return 65% in 2007 and also a very healthy 8% during the financial crisis of 2008. The hedge fund...
Keep Reading →
February 14 - Hedge Funds, News - Comments
In its latest 13F, Incline Global Management, led by Jeff Lignelli, revealed its holdings in its equity portfolio, for the fourth quarter of last year...
Keep Reading →
February 10 - Hedge Funds, News - Comments
To many of your fellow Dr. Reddy’s Laboratories Limited (ADR) (NYSE:RDY) investors, hedge funds are perceived as overrated, outdated investment...
Keep Reading →
September 11 - News - Comments
If you were to ask many traders, hedge funds are viewed as useless, outdated financial tools of a forgotten age. Although there are more than 8,000 hedge...
Keep Reading →
August 29 - News - Comments
In today’s marketplace, there are many metrics market participants can use to track publicly traded companies. A pair of the most innovative are hedge...
Keep Reading →
August 28 - News - Comments
Is Endo Health Solutions Inc (NASDAQ:ENDP) a buy? To many of your fellow readers, hedge funds are viewed as delayed, old investment tools of a forgotten...
Keep Reading →
August 27 - News - Comments
In today’s marketplace, there are tons of indicators investors can use to track the equity markets. A couple of the most underrated are hedge fund and...
Keep Reading →
August 27 - News - Comments
If you were to ask many of your fellow readers, hedge funds are assumed to be overrated, outdated financial tools of an era lost to time. Although there...
Keep Reading →
August 26 - News - Comments
Is Forest Laboratories, Inc. (NYSE:FRX) a sell? If you were to ask many investors, hedge funds are seen as delayed, old financial tools of an era lost...
Keep Reading →
August 25 - News - Comments
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) was in 8 hedge funds’ portfolio at the end of March. TARO investors should pay attention to an increase...
Keep Reading →
July 1 - News - Comments
AT&T Inc. (NYSE:T), General Motors Company (NYSE:GM), and Endo Health Solutions Inc (NASDAQ:ENDP) have announced major developments recently. Here...
Keep Reading →
June 13 - News - Comments
If there were ever any advice I’d wish to impart to the management at Endo Health Solutions Inc (NASDAQ:ENDP)‘s subsidiary Endo Pharmaceuticals...
Keep Reading →
June 3 - News - Comments
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
Keep Reading →
June 3 - News - Comments
United Therapeutics Corporation (NASDAQ:UTHR) shareholders have witnessed a decrease in hedge fund interest of late. If you’d ask most investors...
Keep Reading →
June 3 - News - Comments
Endo Health Solutions Inc (NASDAQ:ENDP) was in 23 hedge funds’ portfolio at the end of March. ENDP has experienced a decrease in activity from the...
Keep Reading →
May 30 - News - Comments
Generic pharmaceutical manufacturer Actavis Inc (NYSE:ACT) made headlines after confirming that it has entered into early stage discussions with Ireland...
Keep Reading →
May 20 - News - Comments
Tomorrow, Warner Chilcott Plc (NASDAQ:WCRX) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting...
Keep Reading →
May 9 - News - Comments
With the SPDR S&P Biotech Index up 37% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
Keep Reading →
April 20 - News - Comments
Earnings season is getting ready to rev into high gear, but earnings are unlikely to be the talk of the sector in the days to come, with three big Food...
Keep Reading →
April 14 - News - Comments
As I noted six weeks ago, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing...
Keep Reading →
April 10 - News - Comments
Endo Health Solutions Inc (NASDAQ:ENDP), a diversified healthcare company specializing in pain medication, has been sending out mixed signals recently...
Keep Reading →
February 26 - News - Comments
Endo Health Solutions Inc (NASDAQ:ENDP) shares popped more than 17% last week on rumors of exploratory talks with potential buyers including Valeant Pharmaceuticals...
Keep Reading →
February 8 - News - Comments